Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher J. Jemapete currently holds 4,000,000 shares of Gene Biotherapeutics, Inc. (CRXM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Jemapete has been a net buyer of CRXM stock. They have purchased $92.0K and sold $0 worth of shares.
Christopher J. Jemapete's most recent insider trade was on Mar 17, 2021, when they purchased 200,000 shares at $0.40 per share.
Christopher J. Jemapete serves as Executive at Gene Biotherapeutics, Inc. (CRXM). They have executed 2 insider transactions totaling $92.0K over their tenure at the company.
Christopher J. Jemapete holds the position of Executive at Gene Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Christopher J. Jemapete has shown a buying trading pattern, with $92.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Christopher J. Jemapete was on Mar 17, 2021, when they purchased $80.0K worth of CRXM shares. This transaction involved 200,000 shares at $0.40 per share.
Christopher J. Jemapete currently owns 4,000,000 shares of Gene Biotherapeutics, Inc. (CRXM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher J. Jemapete's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher J. Jemapete has 2 Form 4 filings on record as an insider at Gene Biotherapeutics, Inc..
Set alerts for Christopher J. Jemapete and 40,000+ other insiders.